drugset / Trial / NCT02525848

Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries

NCT02525848

Phase 2/3 Completed 150 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To evaluate the efficacy of pre-empetive administration of Aprepitant, Versus Gabapentin prophylaxis for reducing the incidence of postoperative nausea and vomiting in Laproscopic gynacological surgeries.

Timeline

Start
2015-08
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aprepitant Other / unclassified 80 mg Oral
Comparator Gabapentin Small molecule 600 mg Oral
Comparator Dexamethasone Small molecule 8 mg Intravenous

Indications

No indication recorded.